Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?
J Geriatr Cardiol
.
2020 Nov 28;17(11):723-727.
doi: 10.11909/j.issn.1671-5411.2020.11.010.
Authors
Bei-Ning Wang
1
,
Yu-Xi Li
2
,
Wei Ma
2
,
Song-Yun Chu
2
,
Zhi-Hao Liu
2
,
Wen-Hui Ding
2
,
Jian-Ping Li
3
Affiliations
1
Department of Nephrology, Peking University First Hospital, Beijing, China.
2
Department of Cardiology, Peking University First Hospital, Beijing, China.
3
Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing, China.
PMID:
33343651
PMCID:
PMC7729177
DOI:
10.11909/j.issn.1671-5411.2020.11.010
No abstract available
Keywords:
Malignancy; Pericardial effusion; Pulmonary hypertension; Superior vena cava syndrome.